2017 SUSTAINABILITY REPORTCREATING A
BETTER WORLDCONTENTS
WHO WE ARE

CREATING A BETTER WORLD

4 About this Report

10 Business Overview

24 Our Goals

6 Letter from our CEO

13 Our Products

29 Our Planet

8 About Medidata

OUR APPROACH

GRI INDEX

14 Stalkholders

30-32 GRI Index

16 Materials

PEOPLE FIRST
18 Ethics
20 Our People
22 Diversity Matters

References:
Priority Issue: An issue deemed material to the company through our sustainability issue
prioritization process.
Global Reporting Initiative (GRI): The GRI Sustainability Reporting Standards are the first andmost widely adopted global standards for sustainability reporting.

UN Global Compact: The UNGC is a voluntary initiative based on CEO commitments to implement
universal sustainability principles and to understand partnerships in support of UN Goals.

Sustainable Development Goals: The SDGs are a universal call to action to end poverty, protect
the planet, and ensure that all people enjoy peace and prosperity.

2

2017 MEDIDATA SUSTAINABILITY REPORT2017 MEDIDATA SUSTAINABILITY REPORT

3

WHO WE ARE

OUR APPROACHPEOPLE FIRSTCREATING A
BETTER WORLDGRI INDEX

WHO WE ARE

OUR APPROACHPEOPLE FIRSTCREATING A
BETTER WORLDGRI INDEX

About this Report

Letter from our CEO

About Medidata

Business Overview

Our Products

About this Report

Letter from our CEO

About Medidata

Business Overview

Our Products

ABOUT THIS REPORTAs we reflect on the last 18 years, the spirit ofinnovation—one that has truly paved the way
for better solutions, higher quality treatments,
and quicker go-to-market times—remains our
foundation and continues to inspire and enable
our customers to dream big. In 2017, we did
extensive research on our policies and how tobest position ourselves as a sustainable company
for the future. Human rights, sustainability, andinnovation are top priorities, so we will primarily
report on these initiatives.
After completing two external audits, we madea formal recommendation to our leadershipteam to proceed with a GRI report in accordancewith the core principles. As a result, this reportcorresponds with the 2017 fiscal year fromJanuary 1, 2017 - December 31, 2017, or thecomplete calendar year. This report marks our
first published GRI report and we anticipate that
we will be reporting annually for the foreseeable
future.
Medidata is a publicly traded NASDAQ company
with headquarters in New York, New York in the
United States (ISIN US58461A1051). Medidata
operates and has offices in seven countries
including the United States, United Kingdom,Japan, Germany, Republic of Korea, Singapore,
and China. Medidata was organized as a New York
corporation in June 1999 and reincorporated in
the State of Delaware in May 2000.

No information contained on our website isintended to be included as part of, or incorporated
by reference into, this Annual Report on Form
10-k. Our Annual Report on Form 10-k, Quarterly
Reports on Form 10-Q, Current Reports on Form
8-k and amendments to those reports filed or
furnished pursuant to Section 13(a) or 15 (d) of
the Exchange Act, as well as reports relating toour securities filed by others pursuant to Section
16 of such act, are available through the investor
relations page of our web site free of charge asreasonably practicable after we electronically filesuch a material with, or furnish it to, the Securities
and Exchange Commission (“SEC”).
This report covers information on all of Medidata’s
employees. The figures stating our number of
employees only includes the full time employees.
When discussing our emission and environmental
impact, we are referring to all of our offices thathave over 100 employees and/or are a data center
including New York City, Iselin, San Francisco,
Houston, London, Tokyo, and Frankfurt.
This report has been prepared in accordancewith the GRI Standards: Core Option. It also uses
the Sustainable Development Goals (SDGs).
If you have any questions or comments regarding
this report, please direct your questions to
Medidata’s Global Corporate Social Responsibility
Lead, Lyndsay Harris, at csr@mdsol.com.

-: 350 Hudson Street, 9th floor
New York, NY 10014': 212-918-1800:: www.mdsol.com

42017 MEDIDATA SUSTAINABILITY REPORT2017 MEDIDATA SUSTAINABILITY REPORT

5

WHO WE ARE

OUR APPROACHPEOPLE FIRSTCREATING A
BETTER WORLDGRI INDEX

About this Report

Letter from our CEO

About Medidata

Business Overview

Our Products

LETTER FROM OUR CEO
In addition to transparency, our strategic priorities
include leaving the world a better place than when
we started. We are creating better, more readily
available treatments but beyond this we strive tobring our mission into the communities we serve,
as we believe our overall impact on society isvastly important to achieving our mission.
It is now more important than ever that we arecommitted to being a sustainable business. A
more diverse workforce will continue to pave
the way for future success, allowing us and ourcustomers to continue to innovate and havean inclusive perspective. This is why we havechosen to report on our economic position, ourenvironmental impact, and above all else, ourhuman rights initiatives.

When we decided to create this report, we asked
ourselves, what can we do to make Medidata moretransparent? As a company, we believe in andsupport innovation on all fronts, but wondered
how far we could push the envelope. Our industry
is undergoing change at a rapid pace, and we haveboth adapted to and propelled this transformation
for almost 20 years. What enables Medidata to
do this? Our diversity of thought and talent, ourinnovative solutions, and our commitment toour mission, powering smarter treatments andhealthier people have driven us. However, are weeffectively portraying our transparent beliefs?
We decided to create this report because wehave always challenged ourselves and we want toexternally showcase our strong company culturethat is inclusive and empowering for all.

62017 MEDIDATA SUSTAINABILITY REPORT

While creating this report in 2018, Medidata
continues to adopt numerous diversity initiatives,
including the 2020 Board pledge, the CEO Callto Action, G100 Membership, and most recently,
we have become signatories of the UN Global
Compact. In 2017, we began to grow our outreach
initiatives in communities where we have offices,
including volunteer outings around the globe
and engaging with our non-profit partners toplan for the years to come. 2017 was a period offoundation, necessary to ensure that our policies
and initiatives reflected our Medidata culture.
Furthermore, we used this time to reflect on our
progress and better understand where we could
make improvements in 2018. We realized that wehave the foundation for a strong program which is
why we decided to accelerate our commitment tocreate real impactful change.

“OUR MISSION TO

IMPROVE PEOPLE’SLIVES TRANSCENDS
THE CLINICAL AND
COMMERCIAL SPACE,
AND I’M PROUD OUREMPLOYEES CONTINUE TO
INVEST THEIR KNOWLEDGE,SKILLS, AND EXPERIENCEFOR THE BETTERMENT OFCOMMUNITIES AROUND
THE WORLD.”

You will see a program in 2018 that is moremeaningful, impactful and sustainable than everbefore. We have a strategy to create true societal
change for our patients and our industry, and knowthat we are positioned well to start driving change.
Our efforts are focused on finding cures for morepatients with an interest in drug repurposing andcreating greater diversity in clinical trials. We also
focus our efforts on educating the next generationof Science, Technology, Engineering, and Math
(STEM) leaders and creating greater genderequality. We plan to work on these initiatives forthe next 5 years, continuing to trailblaze and drive
real innovation and lasting, positive change.

Tarek Sherif, Chairman & CEO

As a Cloud based company, we are pleased
with where we stand, but continually strive for
improvement. While the complexity of our industry
and business present challenges, we are poised
to have a more meaningful impact. Although we
do not own our corporate office buildings, we arestill working on sustainability and influencing ourbuilding owners to think globally.

2017 MEDIDATA SUSTAINABILITY REPORT

7

WHO WE ARE

OUR APPROACHPEOPLE FIRSTCREATING A
BETTER WORLDGRI INDEX

About this Report

Letter from our CEO

About Medidata

Business Overview

Our Products

ABOUT MEDIDATA
As a mission driven cloud based company, we

Medidata has four different categories of products

We power eClinical solutions for over 1,000

individually and collaboratively reinventing theare committed to being excellent corporatethat you can choose from to enhance clinical trial

customers and 100,000 certified users around theway research is done to create smarter, morecitizens. Corporate Social Responsibility (CSR) is

processes from phase I through to FDA approval,

world. We remain true to our roots by maintaining

precise treatments. We provide solutions for thein our DNA, and we believe in holding ourselves

and accelerate more treatments for more

a committed focus on serving the life sciences

patients, doctors, sponsors, and sites to ensureaccountable and continuing to be a transparent

patients. These four categories are Rave (dataindustry, accelerating innovation, and deliveringthat data can easily be captured and analyzed.

and ethical business.
Our unified technology platform empowers thecapture & management), Edge (trial planning &sustainable value to our customers, partners,

management), Medidata Enterprise Data Storeand shareholders as the leader in our vertical.

We’re proud to be helping leading life science(MEDS) & AI, and professional services.

Companies using the Medidata platform areorganizations around the world bring their newlife science community to make clinical trial

treatments to market faster, with reduced cost

breakthroughs, and we provide the only eClinicaland risk. Hundreds of life science organizations

Platform that addresses both the science andhave used our platform, in over 12,000 trials inbusiness operations of drug development—

more than 130 countries. Medidata is a global

leveraging the largest cross-sponsor clinical data

life sciences technology provider, dedicated torepository and deeper data analytics to drive end-

improving the way clinical research is designed,

to-end value from study start to finish.

conducted, and analyzed. Our cloud-based
platform of solutions and data analytics

We have designed our technology to maximize

brings efficiency and quality through clinicalease of use, flexibility, data visibility, and systemdevelopment programs by enhancing decision-scalability to handle high-volume, global trials, asmaking, minimizing operational risk, saving

well as smaller, more customizable studies. We

resources, and transforming trial strategies. We

deploy our solutions through the use of industry-

contract on an enterprise level or on a single-

standard web browsers and mobile devices,

study basis. Subscriptions and professional

service-oriented architectures (“SOA”), three-tiered

services represent approximately 85% and 15%

server architectures, web servers, proprietaryof our business, respectively. Our business model

application servers, and database servers. End

provides us with a recurring revenue stream thatusers can access our solutions via any web

we believe delivers greater revenue visibility thanbrowser from anywhere in the world without

perpetual software licensing models.

downloading or installing any Medidata-specificsoftware. In addition, our cloud-based solutions
feature end-to-end support for unicode characters,
which are required to deliver multilingual studies.
We utilize technologies such as firewalls, intrusion
detection, and encryption to ensure the privacy andsecurity of our customers’ data, with a dedicatedSecurity Information and Event Management teammonitoring our applications.

82017 MEDIDATA SUSTAINABILITY REPORT2017 MEDIDATA SUSTAINABILITY REPORT

9

WHO WE ARE

OUR APPROACHPEOPLE FIRSTCREATING A
BETTER WORLDGRI INDEX

About this Report

Letter from our CEO

About Medidata

Business Overview

Our Products

BUSINESS OVERVIEWCHITA and Mytrus, purchase of $4.1 million in

cash payments for capital expenditures during

cost method investments, and net purchases of2017 were $44.6 million. We expect to spend

marketable securities worth $6.3 million. Cashapproximately $40 million on capital expenditures

provided by financing activities of $99.1 million

during 2018.

consisted of 98 million in net proceeds from theterm loan portion of our credit facility and equity

Medidata did not experience significant changes

plan proceeds of $19.6 million, partially offset byduring the reporting period. Note: Medidata does

the acquisition of $18.5 million in treasury stock

not apply the precautionary principle or approachin connection with equity plan participant tax

in the past. However, we do try to have our offices

withholdings upon vesting.

in LEED certified standards buildings or anequivalent standard.

We acquired $47.8 million in capital assets during
2017, predominantly related to our new officespaces in Seoul, South Korea, and Hammersmith,UK, continued enhancements to our existing
infrastructure and facilities, and capitalization ofsoftware development costs. In 2017 we closed
our Conshohoken, Pennsylvania office. Our actual

As of June 30, 2017, the last business day of thethis report on Form 10-5 and does not represent

registrant’s most recently completed second

an admission by either the registrant of any such

fiscal quarter, the aggregate market value of

person as to the status of such person. As of

the common stock held by non- affiliates of the

February 21, 2018, the registrant had 59,233,261

registrant was approximately $3,445,964,875,

shares of common stock outstanding.

common stock on the NASDAQ global market on

For 2017, cash provided by operating activities

that date of $78.20 per share. For purposes ofof 121.7 million which were 28% higher thandetermining this number, all executive officers

in the prior year, partially offset by operating

and directors of the registrant are consideredexpenditures and cash interest expense on

to be affiliates of the registrant, as well as

our 1.00% convertible senior notes. Cashindividual shareholders holding more than 10%

used in investing activities of $78 millionof the registrant’s outstanding common stock

consisted primarily of cash payments forare considered to be affiliates of the registrant.

capital expenditures of $44.6 million, aggregate

This number is provided only for the purpose of

payments of $22.9 million in aggregate to acquire2017 MEDIDATA SUSTAINABILITY REPORT

1

4Employees

Operation

Product/Services$545,532,000$378,500,000$497,432,000(as of end of FY17)

based on the closing sale price of the registrant’s

10

1,682

Net Sales in 2017

Capitalization Broken Down
in Term of Debt

Capitalization Broken Down
in Term of Equity

These are 2017 numbers and debt was repaid in August 2018.

2017 MEDIDATA SUSTAINABILITY REPORT

11

WHO WE ARE

OUR APPROACHPEOPLE FIRSTCREATING A
BETTER WORLDGRI INDEX

WHO WE ARE

OUR APPROACHPEOPLE FIRSTCREATING A
BETTER WORLDGRI INDEX

About this Report

Letter from our CEO

About Medidata

Business Overview

Our Products

About this Report

Letter from our CEO

About Medidata

Business Overview

Our Products

OUR PRODUCTS
Medidata is a leader in cloud-based software

assembled. MEDS & AI leverages benchmarking,in life sciences, acting as a catalyst for clinicalmachine learning, natural language processing,research and trials with the ultimate goal

anomaly detection, and predictive analytics.

of reducing cost and bringing higher quality

Medidata also brings experts with industry

treatments to patients around the globe. We doexperience who provide transformational andthis through a collection of products including

value-based outcomes through governance,

Rave data capture and management, Edge trial

process optimization, tailored strategies, andplanning and management, MEDS & AI, andbusiness transformation services. We also

professional services.

pioneer the largest life sciences partner ecosystem comprised of CROs, system integrators,

As clinical trials become more and more complex,

and technical alliances, representing industry

Rave captures an increasing number of data

leaders in life sciences and clinical R&D. Our

sources in clinical trials. The Rave Data Capture

implementation team also reduces risk andand Management product suite powers clinicalcustomer burden with timely implementation

trials of the future by automating many of thevia a proven and innovative methodology.

most challenging data management workflows

Lastly, ongoing operational support ensuresacross randomization, supply, coding, and safety.

value realization of the Medidata Clinical Cloud
Platform.

The Edge Trial Planning & Management suitesolves for the patient scarcity and operational
complexity that today’s targeted therapies
create. Powered by MEDS, Edge provides crosssponsor benchmarking to optimize protocol
design, site feasibility, and site grants. Edge also
automates site payments and modernizes study
management with full ICH E6 (R2) Good Clinical
Practice compliance, and automates trial master
files (TMFs).
The MEDS & AI for Data and Intelligence
Management suite embeds actionable intelligence
into every component of clinical development,
powering both the Rave and Edge suite ofproducts. MEDS is the largest cross-sponsor
operational and clinical data repository ever

122017 MEDIDATA SUSTAINABILITY REPORT2017 MEDIDATA SUSTAINABILITY REPORT

13

WHO WE ARE

OUR APPROACH

Stakeholders

Materials

PEOPLE FIRSTCREATING A
BETTER WORLDGRI INDEX

WHO WE ARE

OUR APPROACHPEOPLE FIRSTCREATING A
BETTER WORLDGRI INDEX

About this Report

Letter from our CEO

About Medidata

Business Overview

Our Products

STAKEHOLDERS
We define our stakeholders to be individuals
within the company that directly impact the

STAKEHOLDER ENGAGEMENT

company’s operations and work closely with
our shareholders, clients, employees, andorganizations. Since this is our first report, weconsulted multiple internal partners and thiswas a collaborative effort to determine whatmaterial is highest priority. We did not engage
with our employees that are covered by collective
bargaining agreements as we do not have any.
As noted earlier, we plan to directly engage withseveral stakeholders in 2018 through a material
analysis to determine what should be included in
the report.
The heads of our business reviewed, identified,and classified the various stakeholder groups at
local level. To do so, they used the stakeholder

Employees• We listened to our employees through ourannual global employee survey (MediMic)
and took their feedback into consideration
when compiling this report• Engaging with employees throughour quarterly Town Hall meetings andencouraging questions and open dialogue
on all relevant topics• Listening to our employee’s perspective
through internal blogging

management approach set out in the AA1000SES
standard. As a result, our key stakeholder
groups were considered in accordance with threevariables: Dependence (groups or individuals
who are directly or indirectly dependent on theorganisation’s activities, products, or services
and associated performance), Influence (groups
and individuals who have potential impact on
the organization’s or a stakeholder’s strategic or

Investors• We listened to our investors discuss
topics that are important to them andtook this into consideration

operational decision-making), and Tension (groups
or individuals who need immediate attention fromthe organisation with regard to financial or wider
economic, social, or environmental issues). As thisis our first report, our business leaders decided
to report on feedback they received. In the future,
we plan to conduct a larger stakeholder analysis,but in the interim, decided to report on valuable
insights from our top executives.

142017 MEDIDATA SUSTAINABILITY REPORT

Customers• We considered our customer’s interests
through their Sustainability reports andtheir previous requests for information
when creating this report2017 MEDIDATA SUSTAINABILITY REPORT

15

WHO WE ARE

OUR APPROACH

Stakeholders

Materials

PEOPLE FIRSTCREATING A
BETTER WORLDGRI INDEXMATERIALS
MATERIALITY ASSESSMENT

In order to decide which disclosures are theWe also took into consideration our businessmost relevant to report based on stakeholder

practices and customers to ensure that werequests, we conducted interviews with ourare reporting on information that is the mostinternal executives as noted in our Stakeholder

important to our market. When deciding what

section. This helped us determine what topics are

was material, we looked at market evolution and

OUR BUSINESSOUR PEOPLE

OUR PLANET

the most relevant for our employees and external

what will be important to our customers in thestakeholders.

future. This is how we gauged high, medium, or low

Anti-Corruption

Training and Education

Emissions

HIGH PRIORITY MATERIAL TOPICS

Non-Descrimination

priority topics.

Child Labor

Medidata’s process for defining the report content
started with a small team of our key internal

We presented all of the issues, and in turn, ourForced or Compulsory Labor

stakeholders. We identified a few main issues tointernal stakeholders informed us as to what is at

Employment

focus our materiality on including emission, anti-

the heart of our business and mission.

corruption, training and education, discrimination,
child labor, and forced or compulsory labor.

We will be reporting on topics that are considered

Since this is our first report, we did not completehigh priority.

a full materiality assessment with surveys but
instead decided to utilize our internal team andtheir assessment on what matters most to ourstakeholders. Additionally, we also reviewed

MEDIUM PRIORITY MATERIAL TOPICSOUR BUSINESSOUR PEOPLE

OUR PLANET

Procurement Practices

Customer Privacy

Water

Economic performance

Labor Management

Supplier Environmental assessment

Anti-Competitive

Security Practices

Energythird party audits of which we have been a part,

Human Rights Assessment

including EcoVadis. We made an assumption that

Local Communities

our internal and external stakeholders are aligned

Supplier Social Assessment

based on feedback received from our CEO andPublic Policy

President. Once we complete our first report, weDiversity and Equal Opportunities

can then provide a full materiality assessment toCustomer Healthour external stakeholders. The boundaries we haveset focus on our offices and initiatives globally
unless indicate otherwise.

LOW PRIORITY MATERIAL TOPICSOUR BUSINESSOUR PEOPLE

OUR PLANET

Market Presence

Occupational Health and Safety

Materials

Indirect economic impact

Freedom of Association and Collective
Bargaining

Effluents and Waste

Rights of indigenous peoples

Environmental ComplianceMarketing and labelling

Biodiversity

Socio economic compliance162017 MEDIDATA SUSTAINABILITY REPORT2017 MEDIDATA SUSTAINABILITY REPORT

17

WHO WE ARE

OUR APPROACHPEOPLE FIRST

EthicsOur People

Diversity Matters

CREATING A
BETTER WORLDGRI INDEXETHICS
Medidata takes all necessary measures to ensure

Compliance:

We do not participate in child labor as all of our

We wholeheartedly believe in excellent businessour business leaders and employees are trained

Insider Trading Complianceemployees are required to possess a certain age

morals and ethics, which is why we train ourand informed on the most important policies.

Code of Business Conduct and Ethics

and skill set. We comply with federal regulation

employees, regardless of region, to be able toand do not allow anyone below the age of 16 to

identify and combat bad business practices.

We have a Code of Conduct that is regularly
updated and reviewed by our Executive VP, GeneralCounsel so that our employees, stakeholders,

Overview of Medidata Regulated Content
Management

work at Medidata, and this includes high schoolinternships. While we think it is valuable to offerand customers are aware of our practices. We

Global Privacy Policy and eLearning

the next generation the opportunity to learn about

also offer our employees annual ethics training inReporting Privacy Incidents

STEM careers, we firmly believe in hiring only

English.

Clinical Regs and ERES Overview

adults.

By providing online learning courses, we knowthat our employees are kept up-to-date and arereceiving proper training for various topics ofinterest.

Annual Information Security Briefing 2018
Anti-Phishing Training Course
Salary History and Recruitment Laws

We do not have this information listed in ourcode of conduct, as we have never and will neverMedidata believes the best way to tackle anti-

As a cloud based company, we do not manufacture
any goods and all of our products are therefore

corruption is to make sure our employees are

We also participate in a competitive businessvirtual. We do not have to be concerned withtasked with and prepared to handle issues thatwhich is why we have noted the following in ourforced or compulsory labor, as all of our employees

may come their way. Regardless of the region,code of conduct: the federal government, mostinterview and decide to work for Medidata on their

100% of Medidata’s employees take an anti-

state governments, the European economic

own accord.

corruption course within 30 days of hire. They

community, and many foreign governments

are assigned one of two courses: Anti Corruption

have enacted antitrust or “competition” laws.

Compliance Overview or the Anti Corruption

These laws deal with agreements and practices

Compliance course, based on their region and/“in restraint of trade,” such as price fixing andor position in the company. This is mandatory,

boycotting suppliers or customers. They also

and employees are also required to read our codebar pricing intended to run a competitor outof conduct. This continues up the chain to ourgoverning body. Other courses that employees
are required to take annually include Annual
Information security briefing, and Preventing
Workplace Harassment. Employees are required
to take the below courses upon hiring:of business, disparaging, misrepresenting,or harassing a competitor, and stealing trade
secrets; bribery, and kickbacks. As with allapplicable laws, it is Medidata’s policy to comply
scrupulously with antitrust laws. Moreover,antitrust laws are vigorously enforced. Violations
may result in severe penalties, like forced
sales of business segments, and/or significant
fines against the company. There may also be
sanctions against individual employees, including
substantial fines and/or prison sentences.

18

2017 MEDIDATA SUSTAINABILITY REPORT

Employees

participate in child labor.

Preventing Workplace Harassment
Anti-Corruption Compliance

GOVERNANCE MEMBERS WITHTRAINING OR COMMUNICATION

1,682
1,682

Members
Informed
Members
Trained100%
100%

Members
Informed
Members
Trained

WIthin our Board of Directors, we have four
The diversity of our employees represents a
tremendous asset. We seek to maintain our
reputation as an outstanding employer and toensure high levels of employee motivation andcommitment. Our policy is to treat applicantsand employees the same, regardless of age, race,
creed, color, religion, national origin, gender,
sexual orientation, physical or mental disability,
or any other legally protected classification, andto provide challenging opportunities for individual
growth and advancement free of discriminationand harassment. Medidata prohibits its
employees from engaging in harassing or

standing committees including Audit, Nominatingand Governance, Compensation, and Strategic
Investment & Acquisition (USA Region).
Our Executive Leadership Team is responsible fordecision making on economic, environmental, andsocial project. The information is reported to our
Board of Directors.

discriminatory behavior such as physical orverbal bullying, exclusion, sexual harassment,
inappropriate or offensive physical contact.

2017 MEDIDATA SUSTAINABILITY REPORT

19

WHO WE ARE

OUR APPROACHPEOPLE FIRST

EthicsOur People

Diversity Matters

CREATING A
BETTER WORLDGRI INDEXOUR PEOPLETOTAL NUMBER OF EMPLOYEES BY GENDERTOTAL NUMBER OF CONTRACTORS BY GENDER

Male

1067
63.4%

headcount as of 12/31/17

of Employees

Female609
36.2%

headcount as of 12/31/17

of Employees

Undefined6
0.4%

headcount as of 12/31/17

of Employees

Male

41
63%

contractors as of 12/31/17

of Employees

Female14
21.5%

contractors as of 12/31/17

of Employees

Undefined

10
15.5%

contractors as of 12/31/17

of Employees

Total: 1,682
Note: These numbers do not vary based on seasonal variations orconstruction work.
**Numbers are the entire company, not regional***These numbers reflect our headcount as of 12/31/17.

202017 MEDIDATA SUSTAINABILITY REPORT**Numbers are for USA employees only.
***These numbers reflect our headcount as of 12/31/17.

WE TAKE EMPLOYEE DEVELOPMENTSERIOUSAt over 1.5 million per year, the leadership andemployee development budget allows employees
the opportunity to participate in a global
development curriculum which includes a vast
selection of courses (delivered both internallyand externally by subject matter experts inthe field and online) and workshops covering
strategic thinking, critical thinking, crucial
conversations, business acumen, management
fundamentals, and professional development.
We also provide soft skill training that includes
emotional intelligence, influence and persuasion,
personal branding, and managing your energy.
We have 4 global charters for Toastmasters,with over 140 employees engaged. Global
leadership development programs (also offeredboth internally and externally) are available toanyone director-level and above; our most popularcurrently is our BioPharm course, with over 600
employees have attended this course to-date.
We have a vast amount of online learning throughLinkedIn Learning, Athena, and international
management studies. We have delivered 68
courses across the globe, a 121% increase overthe entire year of 2017. We measured an averagescore of 175% on ROA (return on attendance),reflecting an increase in skill/knowledge from thecourse, and an average score of 4.2 / 5 in utilizing
the information “back at work”. Over 75% of ouremployees have participated in our curriculum.
In 2017 Medidata rolled out a new performanceand review system that gives every employee
three performance review check ins a year withmanagement.

HUMAN RIGHTS MATTER
Medidata is pleased to be among the mostprogressive companies worldwide in establishingenhanced maternity and paternity benefits,
including new parents of adopted children.
“Our new very progressive Parental Paid
Leave program is an important addition to thebenefits we provide and reflects our culture ofvaluing Medidata’s employees and our work/
life balance,” said CEO Tarek Sherif. “This is one
way we can help recognize the importance offamily. We support our moms, dads, and partners
to ensure they have time to spend with new
family members without adding another layerof stress to a special time.” The policy reinforces
Medidata’s commitment to current employees andprovides a distinct advantage in recruiting others,
particularly women, to join our workforce.
Medidata’s 2017 Global Parental Paid Leave
program, when combined with PTO, U.S. shortterm disability, and country-specific social
insurance programs provided new mothers with
6 months of job-protected paid leave. In addition,
paid paternity benefits provided fathers with fourweeks of job-protected leave.
In 2018, we enhanced our policy so that all
new parents receive four months of paid leavefollowing any disability time (a total of six months
for new birth moms). We also added Paid Family
Leave to allow employees four weeks of paid
time to care for a child, parent, parent-in-law,grandchild, grandparent, spouse, or domestic
partner with a serious health condition. Medidata
also offers life insurance, health care, disability
and invalidity coverage, retirement provisions, andstock ownership.

2017 MEDIDATA SUSTAINABILITY REPORT

21

WHO WE ARE

OUR APPROACHPEOPLE FIRST

EthicsOur People

Diversity Matters

CREATING A
BETTER WORLDGRI INDEX

DIVERSITY MATTERS
IT IS OUR DIVERSITY AND INCLUSIVENESS THAT FUELS INNOVATION ANDSPARKS OUR PASSION TO ACCELERATE HOPE FOR OPTIMAL PATIENT HEALTH.
DIVERSITY AND INCLUSION (D&I) ARE EMBEDDED IN OUR CULTURE BECAUSEWE KNOW THAT DIVERSE TEAMS WIN.
DIVERSITY MATTERS TO USOUR CULTURE
Part of our Mission:
Diversity and inclusivenessis in our DNA & has made ourculture a great place to work

22

more diverse than our competitors when it comesin everything we do, remembering that this is

to gender diversity, including the representation

ingrained in our corporate DNA. There’s no otherof women in management positions. However,way to go about it.

the company aims to improve racial and ethnic
diversity, along with the representation of

To identify barriers to D&I at Medidata, in 2017,

women in technical departments. Men are most

Paradigm a diversity analysis expert conducted

overrepresented in technical departments, wherea quantitative and qualitative assessment thatthey account for 73% of current employees.

considered hiring, performance, promotion,

Furthermore, while the representation oftermination, and survey data. They also held

women in management roles is slightly higher

employee interviews, focus groups, and an

than competitors, we aspire to increase thepercentage of women in Medidata women are still

the employee lifecycle. The assessment analyzed

underrepresented in management roles acrossPart of our Mission:
Innovation comes from diverse
perspectives and ideas

how Medidata attracts and selects employees,

major functions at Medidata.

Part of our Mission:
We will better understand allof our customers’ needs when
we represent who they arefrom within the company

Part of our Mission:
We know that diverse teams(with great leadership) makemore revenue and profit

2017 MEDIDATA SUSTAINABILITY REPORT

goals is to embrace diversity & inclusivenessanalysis of Medidata’s people processes across

OUR BUSINESSPart of our Mission:
Employees (and shareholders)should expect that all levels of
the organization will match thedemographics of our markets

Medidata’s current employee population is slightly

OUR PRODUCTSOUR CUSTOMERSOUR PEOPLE

With a core focus on people, one of our corporateand how it develops and retains its workforce.
There are many things Medidata is doing well.

Our assessments and internal reflection helped

89% of employees are proud to work at Medidata

us shape the future of diversity and inclusion

and 79% agree that the company lives by its

at Medidata. Many initiatives have taken shapevalues. Medidata invests in the development ofin 2018, including our newly formed businessemployees through multiple internal training

resource groups (BRGs) which are backed byprograms and has generous, flexible work policies

executive sponsors and charters. During the(almost one quarter of the workforce takes

creation of this report, we have also committed

advantage of remote working opportunities).

to 2020 Women on Boards, Healthcare

However, like many technology companies,

Businesswomen’s Association Gender Parity

Medidata struggles with the representation ofCollaborative study addressing pay parity around

women in leadership and technology departments

the globe, and a CEO Action Diversity initiative.

and Black/African-American and Hispanic/Latino
employees across the organization.

We have continued our commitment by increasingawareness of and training our managers how toaddress unconscious bias and microinequities.
The results of our 2017 inward focus and analysis
created a proactive program that is generating
vast results.

2017 MEDIDATA SUSTAINABILITY REPORT

23

WHO WE ARE

OUR APPROACHPEOPLE FIRSTCREATING A
BETTER WORLDOur Goals

Our Planet

GRI INDEXOUR GOALSCREATING A BETTER WORLD

opportunities expanded dramatically when we

us. Without education in science, technology,

launched our new program in 2018.

engineering, and mathematics, we would not beable to find cures for patients. Although we need

Ensure healthy lives andpromote well-being for all ages

What is Medidata doing?
We are working towards finding
more cures for patients

This more substantive, all-encompassing program

future generations to participate in a world of

in 2018 focuses on initiatives that are yielding a

fast-moving technology and information, manylarger impact. These initiatives include:

students lack access to fundamental resources tomake this a reality.

Ensure inclusive and equitable
quality education and promote
lifelong learning opportunities
for all

Achieve Gender equality andempower all women and girls

What is Medidata doing?
Our goal is to provide 15,000
students with access to STEM
Education in 5 years.

What is Medidata doing?
Working internally and externallyto create a more diverse andinclusive workforce

•
•
•
•

Drug repurposing
Diversity in clinical trials
Employee volunteering initiatives
Patient advocacy charitable runs

In 2017, we continued our support to initiatives
that are local to NYC (headquarters), including ourpartnership with Computer Science NYC and the
NY Academy of Science. Both of these initiatives

Medidata also participated in the Leukemia andsupport students of diverse backgrounds to

Lymphoma Society (LLS) Master Trial, the firstensure that they have access to STEM education.

trial of its kind, where we teamed up with the LLS

We then decided to take our mission a stepand over 20 other companies to participate in thefurther, which is why we created our STEM

Master Trial. This is an ongoing mission to create

strategy and our goal: to be able to provide 15,000

an alternative structure for a clinical trial thatstudents with access to information on careers

will result in more cures for for patients that haveand opportunities in STEM. We do this throughbeen diagnosed with blood cancer.

various initiatives around the globe, and byaligning ourselves with organizations that directly

CURES FOR MORE PATIENTSOur commitment: Patients have always been
our first priority. We are committed to finding
more cures for patients through various means,including drug repurposing and diversity
in clinical trials.
Progress
As we decided to expand our efforts in 2017, wetook the year to decide how we can best impact

242017 MEDIDATA SUSTAINABILITY REPORTa greater amount of patients. We did extensive
research on our program and started with smaller
employee initiatives to generate more thoughtprovoking discussions. Some of our initiatives
included employee-led Hackathons to create
new solutions and encourage more targeted drug
development.

We also created the Social Innovation Lab, ourimpact students and offer opportunities for STEM

think tank that allows our employees to use theireducation.

expertise to create greater opportunities forpatients and drug development.

GENDER EQUALITYSTEM EDUCATIONDiversity matters at Medidata, both internallyand externally, which is why we decided to take

While our employees have always been engaged
in this initiative via our greater company mission,

STEM education is at the heart of Medidata’s corea bold stance on diversity in our workplace init was not until 2017 that we decided to formalize

mission. Over half of our company focuses their2017. We conducted the paradigm assessment to

the program and truly integrate it into our CSR

time on tech related projects; therefore, we viewget a better understanding of what is happening

program as well. Our former initiatives such

STEM education as imperative to the growth andinternally, and have taken many proactive

as charitable runs, and global volunteeringdevelopment of our industry and the world aroundmeasures to create and promote an inclusive

2017 MEDIDATA SUSTAINABILITY REPORT

25

WHO WE ARE

OUR APPROACHPEOPLE FIRSTCREATING A
BETTER WORLDOur Goals

Our Planet

GRI INDEXOUR COMMITMENTS

Medidata became signatories of the
UN Global Compact in July 2018

Medidata has been submitting a private CDP
report since 2015 and plans to provide public
reports in the future.

Medidata is taking action to have 20%of the company’s Board of Directors be
women by 2020.

Medidata became a signatory of the CEO
Action for Diversity and Inclusion.

environment. Our assessment in 2017 directly

While this report was being created, we decided

influenced the program that launched in 2018,

for formalize our commitment to gender equality

which includes three female-led BRGs: Women of

by becoming signatories of the 2020 Women

Color, Women in Tech, and Women at Medidata.

on Board and the CEO Action for Diversity andWe empower women at Medidata to be bold andInclusion. Additionally, Medidata became achallenge the status quo. This led to several

part of HBA’s “Gender Parity Collaborative”— aevocative talks in 2018 to educate our employees

consortium of life sciences companies committed

on the need for and importance of more gender

to diversity, equality, and driving real change in ourequality.

industry.

26

2017 MEDIDATA SUSTAINABILITY REPORT2017 MEDIDATA SUSTAINABILITY REPORT

27

WHO WE ARE

OUR APPROACHPEOPLE FIRSTCREATING A
BETTER WORLDOur Goals

Our Planet

GRI INDEX

WHO WE ARE

OUR APPROACHPEOPLE FIRSTCREATING A
BETTER WORLDOur Goals

Our Planet

GRI INDEXOUR PLANET
As a software company, Medidata is fortunatethat our environmental impact is sufficiently

CO2 EMISSION

less than companies that manufacture products.
However, we continually strive for improvement.
For the last three years, we have submitted nonpublic assessments to the CDP to determine ourenvironmental impact, to identify opportunities todecrease our emissions and energy use.
Medidata aims to build and lease all of our offices
to LEED Gold Certified standards. We do not
own any of our buildings, but believe that it isimperative to position ourselves in offices that

REPORTING ONGROSS OUTPUT (METRIC TONSOF C02 EQUIVALENT)

Scope 10

Scope 2

1,831

Scope 3

6,330.04

Gases

0

Biogenic CO2
emissions0*We used the Greenhouse gas protocol: A corporate Accounting andReporting Standard (Revised Edition)**Due to our data gathering, there is a 10+/- percent uncertainty.

are built to these standards around the globe.
This impacts our vendors selection process andIn 2017, we saw an unprecedented number ofenergy consumption. As we develop the program

natural disasters and two of them occurred in

more, we will be aiming to expand our initiatives toregions where our employees live and work; San

encourage greater sustainability in our offices.

Francisco and Houston. In an effort to support
those local communities, we partnered with the

EMISSIONS
Medidata does not have any scope 1 emissions,
yet we do report our Scope 2 and Scope 3
emissions to the CDP, including our electricity use
and our travel. We do not have financial control
over our emission release and therefore, our data

American Red Cross to launch a matching gift
program and made donations to help those in
need. We take disaster relief seriously, and plan
to continue our support each year as we see theimpact climate change has on various regions of
the world.

was collected based on our operational control.
We do not have additional control of our energy
use as we lease all of our offices.
We see how our planet is being impacted byclimate change. We have taken a proactive
position to better understand our emissions andhow we can decrease them. However, we also takea reactive approach when natural disasters occur
in regions where we have offices and where our
employees are located.

28

2017 MEDIDATA SUSTAINABILITY REPORT2017 MEDIDATA SUSTAINABILITY REPORT

29

WHO WE ARE

OUR APPROACH

CREATING A
BETTER WORLDPEOPLE FIRSTGRI INDEXGLOBAL REPORTING INITIATIVE (GRI) INDEXETHICS AND INTEGRITYORGANIZATIONAL PROFILEGRI STANDARDDISCLOSURE

LOCATION AND NOTESGRI STANDARDDISCLOSURE

LOCATION AND NOTES

102-1

Name of the organization

4102-16

Values, principles, standards, and norms of behavior

30

102-2

Acitivites, brands, products, and services

13

102-3

Location of headquarters

5

102-4

Location of Operations

4

102-5

Ownership and legal form

4

GRI STANDARDDISCLOSURE

LOCATION AND NOTES

102-6

Markets served

8-9

102-18Governance Structure

19

102-7

Scale of the organization

4,11,13

102-8

Information on employees and other workers

19,20,30,31

GOVERNANCE

ADDITIONAL INFORMATION: PART-TIME EMPLOYEES AS OF 12/31/17
NORTH AMERICA

0

EMEA

0

APAC

0

UNDISCLOSED

0**Numbers are the entire company, not regional
A significant portion of Medidata’s activities are not performed by workers who are not employees.

ADDITIONAL INFORMATION: HEADCOUNTS AS OF 12/31/17
NORTH AMERICA

EMEA

APAC

GRAND TOTAL

Contigent workers

113

147

191

451

Employee

1299

227

156

1682

GRAND TOTAL

1412

374

347

2133

**This data was captured in Workday, our Human Resource Information System (HRIS). We pulled a report called the Current Employee Detail Report as of 12/31/17.

STAKEHOLDER ENGAGEMENTGRI STANDARDDISCLOSURE

LOCATION AND NOTES

102-40

List of Stakeholder Groups

14102-41

Collective Bargaining Agreements

14102-42

Identifying and selecting Stakeholders

14102-43

Approach to stakeholder engagement

14

102-44

Key topics and concerns raised

16,17

102-48

Restatements of info

This is not applicable to Medidata

102-49Changes in reporting

This is not applicable to Medidata

GRI STANDARDDISCLOSURE

LOCATION AND NOTES

102-45

Entities included in the consolidated financial statements

31

102-46

Defining reporting content and topic boundaries

4

REPORTING PRACTICE

102-9

Supply Chain

13

102-47

List of Material topics

16,17

102-10Significant changes to the organization and its supply chain

11102-48

Restatements of information

This is not applicable to Medidata

102-11

Precautionary Principle or approach11102-49Changes in Reporting

31

Reporting Period

31102-12External Initiatives

20

102-50102-13

Membership of Associations

26

102-51

Date of most recent report

This is not applicable to Medidata

102-52

Reporting Cycle

4

102-53

Contact point for questions regarding the report

4102-54Claims of reporting in accordance with the GRI standards

4102-55

GRI content index

30-32

102-56External Assurements

31

STRATEGYGRI STANDARDDISCLOSURE

LOCATION AND NOTES

102-14

Statement from Senior decision-maker6, 7

We have not proceed with external assurance and do not plan to do so in the future.

30

2017 MEDIDATA SUSTAINABILITY REPORT2017 MEDIDATA SUSTAINABILITY REPORT

31

WHO WE ARE

OUR APPROACHPEOPLE FIRSTCREATING A
BETTER WORLDGRI INDEXGLOBAL REPORTING INITIATIVE (GRI) INDEXMANAGEMENT APROACHGRI STANDARDDISCLOSURE

LOCATION AND NOTES

103-1

Explanation of the material topic and its Boundaries

4,16,17,18,19,21,29

103-2

Management approach and its components

18,19,21,29

103-3

Evaluation of the management approach

18,19,21,29

GRI STANDARDDISCLOSURE

LOCATION AND NOTES

205-1

Operations assessed for risk related to corruption

18

206-2

Total Governance Body Members

18,19

GRI STANDARDDISCLOSURE

LOCATION AND NOTES

305-2

Scope 2 Emissions

29

305-3

Scope 3 Emissions

29

GRI STANDARDDISCLOSURE

LOCATION AND NOTES

401-2

Full-time only benefits

21

404-2

Training and Education

18,21

404-3

Percentage of employees receiving regular performance and careerdevelopment reviews

21

408-1

Child Labor

19

409-1

Forced or compulsory labor

19

ECONOMICENVIRONMENTAL

SOCIAL32

2017 MEDIDATA SUSTAINABILITY REPORT2017 MEDIDATA SUSTAINABILITY REPORT

33

WHO WE ARE

OUR APPROACHPEOPLE FIRSTCREATING A
BETTER WORLDGRI INDEX

About this Report

Letter from our CEO

About Medidata

Business Overview

Our Products

Medidata Solutions

350 Hudson Street, 9th Floor
New York, NY 10014
USA

ABOUT MEDIDATA

mdsol.com

2017
marked a year of transformation for+1
212.918.1800
Medidata.
After 18
years in business and as+1
212.918.1818(Fax)
we877.511.4200
reflect on the(Tollpast,Free)
present, and future, we+1take pride in our spirit of innovation—one thathas truly paved the way for better solutions,higher quality treatments, and quicker go-toCopyright © 2018 Medidata Solutions, Inc.
markettimes. That spirit continues to drive ourAll
Rights Reserved.
mission, which in turn inspires and enables ourcustomers. We reflected on where we are as acompany overall and how far we have come, but
we also called to mind where we want to be—.
taking the year to do extensive research on ourpolicies and how to best position ourselves asa sustainable company going forward. Human
Rights, Sustainability, and innovation matter to us
most and therefore, it is important that we reporton our initiatives.
After completing two external audits, we madea formal recommendation to our leadershipteam to proceed with a GRI report in accordancewith the core principles. As a result, thisreport corresponds with the 2017 fiscal year
from January 1, 2017- December 31, 2017, thecomplete calendar year. This report marks our
first GRI report to be created to-date.
Medidata has decided to report on an as-neededbasis and therefore, we have not made a formal
decision to proceed with an annual or bi-annual
report. We anticipate that we will be reporting
annually for the foreseeable future. Once wedecide if and when our systems and program aresound, we will proceed with bi-annual reporting.
Medidata is a publicly traded NASDAQ company
with headquarters in New York, New York in the

34

2017 MEDIDATA SUSTAINABILITY REPORT

United States (ISIN US58461A1051). Medidata
operates and has offices in seven countries
including the United States, United Kingdom,Japan, Germany, Republic of Korea, Singapore,
and China. Medidata was organized as a New York
corporation in June 1999 and reincorporated in
the State of Delaware in May 2000.

Principal office: 350 Hudson Street, 9th floor,
New York, NY 10014
Telephone Number: 212-918-1800
Website: www.mdsol.com
No information contained on our website isintended to be included as part of, or incorporated
by reference into, this Annual Report on Form
10-k. Our Annual Report on Form 10-k, Quarterly
Reports on Form 10-Q, Current Reports on Form
8-k and amendments to those reports filed or
furnished pursuant to Section 13(a) or 15 (d) of
the Exchange Act, as well as reports relating toour securities filed by others pursuant to Section
16 of such act, are available through the investor
relations page of our web site free of charge asreasonably practicable after we electronically filesuch a material with, or furnish it to, the Securities
and Exchange Commission (“SEC”).
This report covers information on Medidata’s
United States entities including our headquarters
in New York City. Other offices include Iselin, NJ,
Cincinnati, OH, Houston, TX, and San Francisco,
CA. The figures including our number of
employees only includes the full time employees
within the United States. When discussing
our emission and environmental impact, we